Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,153
archived clinical trials in
Gout

Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
853
mi
from
Phoenix, AZ
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
249
mi
from
Fort Smith, AR
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
249
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1318
mi
from
Santa Clara, CA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1318
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
402
mi
from
Aurora, CO
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
402
mi
from
Aurora, CO
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1330
mi
from
Bridgeport, CT
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1330
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1127
mi
from
Washington,
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1127
mi
from
Washington,
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1128
mi
from
Daytona Beach, FL
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1128
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
805
mi
from
Decatur, GA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
805
mi
from
Decatur, GA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1176
mi
from
Coeur D Alene, ID
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1176
mi
from
Coeur D Alene, ID
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
604
mi
from
Park Ridge, IL
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
604
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
643
mi
from
Indianapolis, IN
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
657
mi
from
Louisville, KY
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
657
mi
from
Louisville, KY
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1148
mi
from
Baltimore, MD
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1444
mi
from
Boston, MA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
808
mi
from
Ann Arbor, MI
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
571
mi
from
Jackson, MS
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
571
mi
from
Jackson, MS
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
211
mi
from
St. Joseph, MO
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
211
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
262
mi
from
Omaha, NE
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
954
mi
from
Henderson, NV
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
954
mi
from
Henderson, NV
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
523
mi
from
Albuquerque, NM
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
523
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1290
mi
from
New York, NY
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1290
mi
from
New York, NY
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
858
mi
from
Ashville, NC
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
858
mi
from
Ashville, NC
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
645
mi
from
Bismarck, ND
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
645
mi
from
Bismarck, ND
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
895
mi
from
Cleveland, OH
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
895
mi
from
Cleveland, OH
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
156
mi
from
Tulsa, OK
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
156
mi
from
Tulsa, OK
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1383
mi
from
Portland, OR
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1064
mi
from
Charleston, SC
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1064
mi
from
Charleston, SC
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
719
mi
from
Chattanooga, TN
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
719
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
349
mi
from
Dallas, TX
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
779
mi
from
Salt Lake City, UT
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1181
mi
from
Norfolk, VA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1181
mi
from
Norfolk, VA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
1410
mi
from
Seattle, WA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
683
mi
from
Birmingham, AL
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
853
mi
from
Phoenix, AZ
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
249
mi
from
Fort Smith, AR
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
249
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
1318
mi
from
Santa Clara, CA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
1318
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
402
mi
from
Aurora, CO
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
402
mi
from
Aurora, CO
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
1330
mi
from
Bridgeport, CT
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
1330
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
1128
mi
from
Daytona Beach, FL
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
1128
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
805
mi
from
Decatur, GA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
805
mi
from
Decatur, GA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
3717
mi
from
Honolulu, HI
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
1176
mi
from
Coeur D Alene, ID
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
1176
mi
from
Coeur D Alene, ID
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
604
mi
from
Park Ridge, IL
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
604
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
643
mi
from
Indianapolis, IN
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
643
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
469
mi
from
Bettendorf, IA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
469
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
190
mi
from
Overland Park, KA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
190
mi
from
Overland Park, KA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
657
mi
from
Louisville, KY
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
657
mi
from
Louisville, KY
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
690
mi
from
Metairie, LA
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
690
mi
from
Metairie, LA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  7/15/2013
Clinical Research Facility
1148
mi
from
Baltimore, MD
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 7/15/2013
Clinical Research Facility
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials